Che‐Ming Jack Hu

15.8k total citations · 5 hit papers
82 papers, 11.7k citations indexed

About

Che‐Ming Jack Hu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Che‐Ming Jack Hu has authored 82 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Biomedical Engineering and 23 papers in Biomaterials. Recurrent topics in Che‐Ming Jack Hu's work include Nanoparticle-Based Drug Delivery (21 papers), Immunotherapy and Immune Responses (17 papers) and RNA Interference and Gene Delivery (15 papers). Che‐Ming Jack Hu is often cited by papers focused on Nanoparticle-Based Drug Delivery (21 papers), Immunotherapy and Immune Responses (17 papers) and RNA Interference and Gene Delivery (15 papers). Che‐Ming Jack Hu collaborates with scholars based in United States, Taiwan and China. Che‐Ming Jack Hu's co-authors include Liangfang Zhang, Ronnie H. Fang, Santosh Aryal, Brian T. Luk, Weiwei Gao, Jonathan A. Copp, Connie Cheung, Li Zhang, Yi‐Yin Tai and Cody W. Carpenter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Che‐Ming Jack Hu

78 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

2011 2.0k citations Che‐Ming Jack Hu, Santosh Aryal et al. profile →
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

2014 1.3k citations Ronnie H. Fang, Che‐Ming Jack Hu et al. profile →
A biomimetic nanosponge that absorbs pore-forming toxins

2013 630 citations Che‐Ming Jack Hu, Ronnie H. Fang et al. Nature Nanotechnology profile →
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

2012 574 citations Che‐Ming Jack Hu, Liangfang Zhang profile →
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles

2015 421 citations Weiwei Gao, Ronnie H. Fang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Che‐Ming Jack Hu United States	42	6.7k	5.2k	5.2k	1.7k	1.2k	82	11.7k
Brian T. Luk United States	29	5.0k 0.7×	3.3k 0.6×	3.9k 0.8×	1.6k 1.0×	809 0.7×	35	8.2k
Aaron C. Anselmo United States	41	4.4k 0.7×	4.0k 0.8×	4.1k 0.8×	1.1k 0.6×	1.9k 1.6×	69	11.5k
Weiwei Gao United States	75	11.4k 1.7×	5.7k 1.1×	8.2k 1.6×	3.2k 1.9×	2.4k 1.9×	215	20.4k
Haifa Shen United States	46	4.4k 0.7×	4.4k 0.8×	5.6k 1.1×	1.4k 0.8×	1.7k 1.3×	125	11.6k
Dan Peer Israel	57	6.7k 1.0×	7.5k 1.4×	9.7k 1.9×	2.0k 1.2×	2.5k 2.0×	155	18.6k
Ronnie H. Fang United States	74	12.9k 1.9×	7.8k 1.5×	9.8k 1.9×	3.9k 2.3×	2.5k 2.0×	165	22.1k
Thomas L. Andresen Denmark	55	3.3k 0.5×	3.8k 0.7×	5.4k 1.0×	934 0.6×	1.1k 0.9×	264	10.7k
Michael J. Mitchell United States	52	5.5k 0.8×	3.8k 0.7×	8.2k 1.6×	3.4k 2.0×	1.5k 1.2×	164	16.8k
Bruno G. De Geest Belgium	57	3.1k 0.5×	3.7k 0.7×	3.1k 0.6×	1.7k 1.0×	1.6k 1.3×	256	11.2k
Jinjun Shi United States	66	9.3k 1.4×	6.9k 1.3×	8.4k 1.6×	2.3k 1.4×	4.7k 3.8×	138	20.2k

Countries citing papers authored by Che‐Ming Jack Hu

Since Specialization

Citations

This map shows the geographic impact of Che‐Ming Jack Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che‐Ming Jack Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che‐Ming Jack Hu more than expected).

Fields of papers citing papers by Che‐Ming Jack Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Che‐Ming Jack Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che‐Ming Jack Hu. The network helps show where Che‐Ming Jack Hu may publish in the future.

Co-authorship network of co-authors of Che‐Ming Jack Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Che‐Ming Jack Hu. A scholar is included among the top collaborators of Che‐Ming Jack Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Che‐Ming Jack Hu. Che‐Ming Jack Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Chung‐Yao, Pei‐Yun Tsai, Jung‐Chen Lin, et al.. (2025). Polymerised superparamagnetic antigen presenting cell lymphocyte capture for enriching tumour reactive T-cells and neoantigen identification. Nature Communications. 16(1). 5088–5088.

Liu, Qiao, et al.. (2025). Harnessing cytokines: innovative adjuvants for improved veterinary vaccine efficacy. Frontiers in Immunology. 16. 1643855–1643855.

Lin, Wen-Ching, et al.. (2024). Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO Molecular Medicine. 16(2). 416–428. 8 indexed citations

Hu, Che‐Ming Jack, et al.. (2024). An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity. International Journal of Nanomedicine. Volume 19. 7201–7214.

Lin, Wen‐Ching, et al.. (2024). High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression. Advanced Science. 11(33). e2310204–e2310204. 2 indexed citations

Khan, Shahid Ali, et al.. (2024). Fabrication of cyborg bacterial cells as living cell–material hybrids using intracellular hydrogelation. Nature Protocols. 19(12). 3613–3639. 3 indexed citations

Hsu, Chung‐Yao, Yuhan Liu, Jung‐Chen Lin, et al.. (2023). Rapid plasma membrane isolation via intracellular polymerization-mediated biomolecular confinement. Acta Biomaterialia. 173. 325–335. 9 indexed citations

Khan, Shahid Ali, et al.. (2023). Synthetic control of living cells by intracellular polymerization. Trends in biotechnology. 42(2). 241–252. 19 indexed citations

Lin, Leon C. W., et al.. (2023). Lymph Node Follicle‐Targeting STING Agonist Nanoshells Enable Single‐Shot M2e Vaccination for Broad and Durable Influenza Protection. Advanced Science. 10(17). e2206521–e2206521. 9 indexed citations

10.

Lin, Jung‐Chen, et al.. (2021). Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control. Drug Delivery and Translational Research. 11(4). 1420–1437. 19 indexed citations

11.

Lin, Shuyi, et al.. (2020). <p>Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens</p>. International Journal of Nanomedicine. Volume 15. 3303–3318. 22 indexed citations

12.

Chattopadhyay, Saborni, et al.. (2017). Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation. Nanotheranostics. 1(3). 244–260. 126 indexed citations

13.

Dehaini, Diana, Ronnie H. Fang, Brian T. Luk, et al.. (2016). Ultra-small lipid–polymer hybrid nanoparticles for tumor-penetrating drug delivery. Nanoscale. 8(30). 14411–14419. 81 indexed citations

14.

Hu, Che‐Ming Jack & Liangfang Zhang. (2014). Nanotoxoid vaccines. Nano Today. 9(4). 401–404. 30 indexed citations

15.

Hu, Che‐Ming Jack, Ronnie H. Fang, Brian T. Luk, & Liangfang Zhang. (2013). Nanoparticle-detained toxins for safe and effective vaccination. Nature Nanotechnology. 8(12). 933–938. 292 indexed citations

16.

Hu, Che‐Ming Jack, Ronnie H. Fang, Brian T. Luk, & Liangfang Zhang. (2013). Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale. 6(1). 65–75. 166 indexed citations

17.

Fang, Ronnie H., et al.. (2012). Large-Scale Synthesis of Lipid–Polymer Hybrid Nanoparticles Using a Multi-Inlet Vortex Reactor. Langmuir. 28(39). 13824–13829. 59 indexed citations

18.

Balasubramanian, Shankar, Daniel Kagan, Che‐Ming Jack Hu, et al.. (2011). Micromachine‐Enabled Capture and Isolation of Cancer Cells in Complex Media. Angewandte Chemie International Edition. 50(18). 4161–4164. 363 indexed citations

19.

Aryal, Santosh, Che‐Ming Jack Hu, & Liangfang Zhang. (2010). Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery. Small. 6(13). 1442–1448. 160 indexed citations

20.

Hu, Che‐Ming Jack & Liangfang Zhang. (2009). Therapeutic Nanoparticles to Combat Cancer Drug Resistance. Current Drug Metabolism. 10(8). 836–841. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact